Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Proteomics|November 11, 2009
Improved preparation and detection of cytochrome P450 isoforms using MS methodsChris W Sutton, Mark Sutherland, Steve Shnyder, et al.Cancers|November 12, 2013
RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone MetastasisMark Sutherland, Andrew Gordon, Steven D Shnyder, et al.The Analyst|August 13, 2016
An optimised assay for quantitative, high-throughput analysis of polysialyltransferase activitySara M Elkashef, Mark Sutherland, Laurence H Patterson, et al.Proteomics. Clinical Applications|May 11, 2017
Nipple aspirate fluid-A liquid biopsy for diagnosing breast healthSadr-Ul Shaheed, Catherine Tait, Kyriacos Kyriacou, et al.British Journal of Pharmacology|November 15, 2011
The role of targeted chemical proteomics in pharmacologyChris W SuttonDrug Metabolism Reviews|September 7, 2002
Bioreductively activated antitumor N-oxides: the case of AQ4N, a unique approach to hypoxia-activated cancer chemotherapyLaurence H PattersonChemmedchem|May 8, 2016
Rational Development of Novel Activity Probes for the Analysis of Human Cytochromes P450Jonathan D Sellars, Mark Skipsey, Sadr-Ul-Shaheed, et al.Current Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Resistance in cancer: a target for drug discoveryMark Searcey, Laurence H PattersonCurrent Topics in Medicinal Chemistry|October 27, 2005
DNA mismatch repair deficiency, resistance to cancer chemotherapy and the development of hypersensitive agentsKlaus Pors, Laurence H PattersonJournal of Medicinal Chemistry|February 27, 2014
Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonistsHelen M Sheldrake, Laurence H PattersonPageof 10